 |
 |
Below is a list of previous ALZET promotions and names for the corresponding winners. Congratulations to the lucky winners, and thank you to all scientists who participated in these special ALZET promotions:
Bibliography Update 2007: The winner of the iPod nano is Karine Lux from the Jackson Laboratory - Sacramento
SFN 2007: The winner of the iPod touch is Melissa Ferguson from University of Florida - Gainesville
Neuroscience Newsletter Mailing 2007: The winner of the Apple iPod nano is Andrea Neely from University of North Carolina - Chapel Hill
Bibliography Update Mailer 2007: The winner of the Apple iPod nano is Dr. Linda Gutierrez from Wilkes University.
Endocrine Society 2007: The winner of the Apple iPod nano is Dr. Gunapala Shetty from the MD Anderson Cancer Center.
Experimental Biology 2007: The winner of the Apple iPod nano is Dr. Tandra Chakraborty from Adelphi University.
AACR 2007: The winner of the Apple iPod nano is Dr. Christopher Gubish from the University of Pittsburgh.
SOT 2007: The winner of the Apple iPod nano is Carroll Henschel from BioMarin Pharmaceutical Inc.
Product News
ALZET
introduces new pump model (2006)
Available Now
Model 2006 Nominal Specifications:
-
Volume: 200 µl
-
Release rate: 0.15 µl/hour
-
Duration: 6 weeks
Key features:
-
Longest duration pump in any size, ideal for chronic studies in mice, rats, and other animal models
-
Low flow rate, ideal for tissue perfusion
ALZET introduces new pump model (1004)
Model 1004 Nominal Specifications:
-
Volume: 100 µl
-
Release rate: 0.11 µl/hour
-
Duration: 4 weeks
Key features:
-
Longest duration pump in 100 µl size; ideal for chronic studies in small mice and young rats
-
Slowest flow rate in ALZET product line, ideal for tissue perfusion
ALZET Osmotic Pumps Celebrate 30 Years of Continuous Delivery
Introduced in 1977, this year marks 30 years since the first ALZET Osmotic Pump was sold. Over the last three decades the ALZET pumps have been proven as an integral research tool, allowing for the continuous delivery of test compounds.
ALZET introduces three new specialized catheters.
These catheters are fully compatible with the ALZET Osmotic Pumps and are constructed from biocompatible materials. See more information on our catheter page. The various models include the following:
-
Rat Intrathecal Catheter - Short
-
Mouse Jugular - Adjustable Length
-
Mouse Jugular - Adjustable Length/Large Tip
Company News
7/17/2007
DURECT Reports Positive Results from POSIDUR(TM) Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed
6/27/2007
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
1/3/2007
DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
11/29/06
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR(TM) in Europe and Other Select Countries
Latest Research Using ALZET Pumps
Steroid hormones act transsynaptically within the Forebrain to regulate neuronal phenotype and song stereotypy. JOURNAL OF NEUROSCIENCE 2007; 27(44):12045-12057. >>> Meitzen J, et al.
Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Letters 2007; 247(1):143-149. >>> Zhang X, Connolly C, et al. "Continuous administration of 3TSR reduced dosage and improved therapeutic potency."
Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase. J Med Chem 2007. >>> Mortlock AA, Foote KM, Heron NM, Jung FH, Pasquet G, Lohmann JJ et al.
Evaluation of an osmotic pump for microdialysis sampling in an awake and untethered rat. J Neurosci Methods 2007; 160(2):269-275. >>> Cooper JD, Heppert KE, Davies MI, Lunte SM. "the osmotic pump can be an invaluable improvement over the syringe pump.".
